IFPMA Statement: UNODC Commission on Crime Prevention and Criminal Justice, 22nd session
25 April 2013
© IFPMA
IFPMA Statement - WHO Executive Board, 132nd session IFPMA Statement under agenda item 9.2 “Neglected Tropical Diseases”
25 January 2013
© IFPMA
IFPMA Statement- WHO Executive Board, 132nd session IFPMA Statement under agenda item 10.2 “Follow-up of the report of the Consultative Expert Working Group on Research and Development: Financing and Coordination”
25 January 2013
© IFPMA
IFPMA Statement - WHO Executive Board, 132nd session IFPMA Statement under agenda item 8.2 “Pandemic influenza preparedness: sharing of influenza viruses and access to vaccines and other benefits”
24 January 2013
© IFPMA
IFPMA Statement - WHO Executive Board, 132nd session IFPMA Statement under agenda item 5 “Key issues for the development of a policy on engagement with NGOs”
23 January 2013
© IFPMA
IFPMA Statement - Open-ended meeting of Member States on the follow-up of the report of the Consultative Expert Working Group on Research and Development: Financing and Coordination (CEWG)
26 November 2012
05 February 2013,
Technical Briefing: Making Natural Product Research Work
UPDATED! Developing World Health Partnerships Directory
The research-based pharmaceutical industry engages in a wide range of public-private partnerships...
IFPMA Code of Practice
Expanded IFPMA Code of Practice updates ethical and professional standards for interacting with...
IFPMA Clinical Trials Portal and Joint Positions on Clinical Trial Results Publication and...
Important online sources of clinical trials information